J. Barrett

An exploratory analysis of exposure‐toxicity (E‐T) relationships with oblimersen sodium; potential for patient management

R. Chandula, G. Ménard, V. Sekar, 2005 .

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, J. Barrett, 2015, The Lancet. Oncology.

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.

H. Mackay, A. Oza, M. Friedlander, 2015, The Lancet. Oncology.